Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
I'm LongbridgeAI, I can summarize articles.iSpecimen shares surged 27.9% in pre-market trading after announcing a $4.5 million acquisition of Foldlab AI assets. Other notable movers include CEA Industries, which gained 81.3%, and Focus Universal, which plummeted 51.2%. The pre-market session also saw significant gains for GMEX Robotics and BrenX, while major declines were recorded by Dyne Therapeutics and Novartis AG following trial results.
Shares of iSpecimen Inc (NASDAQ:ISPC) rose sharply in pre-market trading after the company announced plans to acquire Foldlab AI assets for $4.5 million, including AI models, software and intellectual property.
iSpecimen shares jumped 27.9% to $1.97 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- CEA Industries Inc (NASDAQ:BNC) gained 81.3% to $6.33 in pre-market trading after adding 6% on Friday.
- GMEX Robotics Corp (NASDAQ:GMEX) rose 48.6% to $1.10 in pre-market trading after falling 5% on Friday.
- BrenX Ltd. (NASDAQ:BRNX) gained 25% to $2.80 in pre-market trading after falling around 26% on Friday.
- Wing Yip Food Holdings Group (NASDAQ:WYHG) gained 19.7% to $4.86 in pre-market trading.
- OceanPal Inc (NASDAQ:SVRN) rose 19.1% to $10.80 in pre-market trading after dipping 14% on Friday.
- Super League Enterprise, Inc. (NASDAQ:SLE) rose 17.1% to $4.59 in pre-market trading after gaining 11% on Friday.
- Boxabl Inc. (NASDAQ:BXBL) rose 12.6% to $4.90 in pre-market trading.
- Singularity Future Technology Ltd. (NASDAQ:SGLY) gained 9.1% to $1.5055 in pre-market trading following a 6% decline on Friday.
- Waterdrop Inc. (NYSE:WDH) gained 7.2% to $1.1197 in pre-market trading. Waterdrop will report second quarter financial results on Sept. 8.
Losers
- Focus Universal Inc (NASDAQ:FCUV) tumbled 51.2% to $8.30 in pre-market trading after dipping around 14% on Friday.
- Dyne Therapeutics, Inc (NASDAQ:DYN) fell 35.5% to $15.64 in pre-market trading. Dyne Therapeutics will present preclinical data for multiple development candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting.
- bioAffinity Technologies Inc (NASDAQ:BIAF) fell 22.5% to $11.82 in pre-market trading after gaining 19% on Friday.
- Onconetix Inc (NASDAQ:ONCO) declined 21.6% to $0.80 in pre-market trading after jumping 38% on Friday.
- Turbogen Ltd (NASDAQ:TRBG) fell 19.4% to $5.91 in pre-market trading after dipping 38% on Friday.
- CL Workshop Group Ltd – ADR (NASDAQ:NWGL) fell 17.3% to $1.05 in pre-market trading after gaining 23% on Friday.
- Scienjoy Holding Corp (NASDAQ:SJ) fell 16.3% to $0.87 in pre-market trading. Scienjoy recently announced plans to buy 29.9% of Leader Education for about $13.1 million.
- Sarepta Therapeutics Inc (NASDAQ:SRPT) fell 15.6% to $19.00 in pre-market trading. Sarepta Therapeutics, last month, posted upbeat quarterly results.
- Novartis AG (NYSE:NVS) fell 12.7% to $139.56 in pre-market trading after the company disclosed that the pelacarsen phase III Lp(a) HORIZON trial did not meet its primary endpoint.
- OFA Group (NASDAQ:OFAL) fell 11.7% to $0.69 in pre-market trading. OFA Group shares jumped 15% on Friday after the company announced its QikBIM platform logged more than 280,000 views and thousands of new followers in its first 90 days.
Photo via Shutterstock